<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Heart transplantation in adults: Arrhythmias</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Heart transplantation in adults: Arrhythmias</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Heart transplantation in adults: Arrhythmias</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Howard J Eisen, MD, FACC, FAHA, FHFSA, FAST</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Luke S Kusmirek, MD, FACC</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sharon A Hunt, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 03, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cardiac arrhythmias are common in the orthotopic heart transplant recipient, particularly in the early postoperative period. Premature atrial complexes and premature ventricular complexes are especially frequent, with a reported incidence of over 60 percent. Fortunately, these arrhythmias have little clinical importance. However, other cardiac arrhythmias, such as sinus node dysfunction and ventricular tachycardia, may result in significant morbidity or mortality.</p><p>Prognosis and other clinical issues following cardiac transplantation are discussed separately. (See  <a class="medical medical_review" href="/d/html/3523.html" rel="external">"Heart transplantation in adults: Prognosis"</a> and  <a class="medical medical_review" href="/d/html/3530.html" rel="external">"Heart transplantation in adults: Induction and maintenance of immunosuppressive therapy"</a> and  <a class="medical medical_review" href="/d/html/3522.html" rel="external">"Heart transplantation: Clinical manifestations, diagnosis, and prognosis of cardiac allograft vasculopathy"</a> and  <a class="medical medical_review" href="/d/html/3524.html" rel="external">"Heart Transplantation: Prevention and treatment of cardiac allograft vasculopathy"</a> and  <a class="medical medical_review" href="/d/html/3526.html" rel="external">"Heart transplantation in adults: Graft dysfunction"</a> and  <a class="medical medical_review" href="/d/html/3519.html" rel="external">"Heart transplantation in adults: Diagnosis of allograft rejection"</a> and  <a class="medical medical_review" href="/d/html/3520.html" rel="external">"Heart transplantation in adults: Treatment of rejection"</a> and  <a class="medical medical_review" href="/d/html/3527.html" rel="external">"Heart transplantation in adults: Exercise-based rehabilitation for transplant recipients"</a> and  <a class="medical medical_review" href="/d/html/3529.html" rel="external">"Heart transplantation in adults: Pregnancy after transplantation"</a> and  <a class="medical medical_review" href="/d/html/3521.html" rel="external">"Heart transplantation: Hyperlipidemia after transplantation"</a> and  <a class="medical medical_review" href="/d/html/7304.html" rel="external">"Malignancy after solid organ transplantation"</a>.)</p><p class="headingAnchor" id="H24872074"><span class="h1">MECHANISMS</span><span class="headingEndMark"> — </span>There are several mechanisms for arrhythmogenesis in the transplanted heart, with early postoperative arrhythmias resulting from different mechanisms than those occurring later. Surgical trauma to the sinoatrial and atrioventricular nodes, ischemia during preservation, surgical suture lines, and, over the long term, rejection and accelerated atherosclerosis may contribute to the formation of an arrhythmogenic substrate. As an example, one autopsy study of 18 hearts found that acute rejection involved the conduction system as severely as the myocardium [<a href="#rid1">1</a>]. With chronic rejection, there was often obstructive vasculopathy of the sinus node artery. </p><p>In occasional cases, severe rejection isolated to the conduction system with sparing of the rest of the myocardium occurs and presents as bradycardia with syncope [<a href="#rid2">2</a>].</p><p>In addition, the denervated donor heart has increased sensitivity to sympathetic amines, <a class="drug drug_general" data-topicid="9359" href="/d/drug information/9359.html" rel="external">adenosine</a>, and acetylcholine, which may contribute to both tachyarrhythmias and bradyarrhythmias [<a href="#rid3">3-5</a>]. The sympathetic effect may be presynaptic in origin; it is not due to increased beta receptor density [<a href="#rid3">3,4</a>]. </p><p>Because of this increased sinus node sensitivity, <a class="drug drug_general" data-topicid="9359" href="/d/drug information/9359.html" rel="external">adenosine</a> should generally not be used (as it often used is in other patient populations) to slow the rate in supraventricular tachyarrhythmias to elucidate the underlying arrhythmia mechanism. Such use can result in prolonged bradycardia or a period of asystole. Cautious use of IV adenosine in selected pediatric and young adult transplant patients was well tolerated in one single center study [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H2"><span class="h1">SINUS RATE</span><span class="headingEndMark"> — </span>In the denervated heart, the normal resting sinus rate is usually greater than 80 bpm and may exceed 100 bpm in hearts transplanted from young donors. The heart rate is higher than in normals because of the loss of vagal neural inputs, which have a negative chronotropic effect. (See  <a class="medical medical_review" href="/d/html/1074.html" rel="external">"Sinus tachycardia: Evaluation and management"</a>.)</p><p>Partial reinnervation of cardiac sympathetic nerves after transplantation occurs in about one-third of patients at one year [<a href="#rid7">7-10</a>]. The process of reinnervation continues gradually for up to 15 years but is regionally heterogeneous [<a href="#rid10">10,11</a>]. Reinnervation of the sinus node is accompanied by partial restoration of the normal heart rate response to exercise [<a href="#rid8">8,9</a>].</p><p>Vagal innervation appears to be absent in the majority of patients for up to 96 months after transplant [<a href="#rid12">12</a>]. Vagal reinnervation may depend upon surgical technique; it occurs more commonly with bicaval compared with the standard biatrial surgery [<a href="#rid13">13</a>]. Standard biatrial surgery transects about 50 percent of sympathetic fibers, but most recipient vagus nerve trunks remain intact. As a result, there is a stimulus for sympathetic fiber, but not vagal fiber, regeneration. In contrast, bicaval surgery transects both sympathetic and parasympathetic fibers and regeneration may be stimulated in both branches.</p><p>Persistent post-transplant sinus tachycardia is associated with decreased long-term survival. The role of agents to reduce heart rate (beta blocker or <a class="drug drug_general" data-topicid="101166" href="/d/drug information/101166.html" rel="external">ivabradine</a>) in this setting has not been established. A preliminary observational study found that 2 year survival was higher in patients treated with ivabradine compared to patients treated with <a class="drug drug_general" data-topicid="9645" href="/d/drug information/9645.html" rel="external">metoprolol</a> [<a href="#rid14">14</a>]. Further study is required to determine the efficacy of these drugs in this setting.  </p><p class="headingAnchor" id="H3"><span class="h1">SINUS NODE DYSFUNCTION</span></p><p class="headingAnchor" id="H414526054"><span class="h2">Prevalence and causes</span><span class="headingEndMark"> — </span>Sinus node dysfunction (SND), which is usually manifested by a relative bradycardia, occurs in up to 50 percent of patients in the first several weeks following transplantation [<a href="#rid15">15-17</a>]. Although this early abnormality does not appear to affect mortality [<a href="#rid18">18,19</a>], sinus bradycardia may result in significant morbidity from decreased cardiac output. In a series of 1179 heart transplants (91 percent with biatrial technique) performed over 35 years, 11.5 percent required pacemaker implantation to treat bradycardia; 86 percent of patients requiring a pacemaker had SND [<a href="#rid19">19</a>]. Independent risk factors for pacemaker implantation were prolonged operative time and a biatrial anastomosis. (See  <a class="medical medical_review" href="/d/html/896.html" rel="external">"Sinus node dysfunction: Clinical manifestations, diagnosis, and evaluation"</a> and  <a class="medical medical_review" href="/d/html/940.html" rel="external">"Sinus node dysfunction: Epidemiology, etiology, and natural history"</a>.)</p><p>In cardiac transplant recipients with SND, intact atrioventricular nodal function is usually present; thus, atrial pacing is often sufficient but usually delivered with a dual chamber pacemaker capable of ventricular backup pacing if needed [<a href="#rid20">20</a>]. Lead dislodgement during endomyocardial biopsy rarely occurs. (See  <a class="medical medical_review" href="/d/html/941.html" rel="external">"Permanent cardiac pacing: Overview of devices and indications"</a>.)</p><p>Potential causes of SND include ischemia during hypothermic preservation; surgical trauma to the sinus node, perinodal atrial tissue, or sinoatrial artery; pretransplant use of <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a>; and immunologic processes such as rejection [<a href="#rid17">17,21</a>]. In one series, for example, patients who required permanent pacemakers for sinus bradycardia had a significantly higher prevalence of abnormal sinoatrial nodal arteries when compared to a control group of heart transplant recipients with normal sinus node function [<a href="#rid22">22</a>]. </p><p>Surgical trauma to the sinoatrial artery can be avoided by performing a bicaval anastomosis rather than the standard biatrial anastomosis [<a href="#rid19">19,23,24</a>]; thus, the bicaval technique has become the most commonly used procedure in transplant centers [<a href="#rid25">25</a>]. This technique consists of total excision of the right atrium with a minimum cuff of left atrium remaining around the four pulmonary veins, followed by direct anastomoses of the donor and recipient vena cavae. It appears to be associated with a decreased incidence of SND [<a href="#rid26">26-28</a>]. In a prospective series of 70 orthotopic heart transplant recipients undergoing either a standard biatrial or a bicaval anastomosis, the incidence of SND, as determined by atrial pacing techniques, was much lower with bicaval anastomosis (5 versus 44 percent) [<a href="#rid28">28</a>]. This finding was confirmed in a United Network for Organ Sharing/Organ Procurement and Transplantation Network (UNOS/OPTN) database analysis of 20,999 recipients indicating that those transplanted utilizing bicaval anastomosis had lesser need for pacemaker therapy and improved long-term survival [<a href="#rid29">29</a>].</p><p>Several studies have suggested correlation of bradycardia with the donor ischemic time [<a href="#rid16">16,30,31</a>]; however, in other series, the donor ischemic time was not significantly different for orthotopic heart transplant recipients who required implantation of a permanent pacemaker for sinus bradycardia compared with those without this complication [<a href="#rid19">19,22</a>]. </p><p>A separate UNOS/OPTN database analysis of 35,987 patients reported a 10.9 percent incidence of pacemaker-requiring bradyarrhythmias [<a href="#rid32">32</a>]. A biatrial anastomosis as well as greater recipient and donor age were the only factors associated with increased permanent pacemaker requirement. Pacemaker implantation had no adverse effect on survival; in fact, survival was better in pacemaker recipients as compared to those not receiving a pacemaker.</p><p class="headingAnchor" id="H28084306"><span class="h2">Treatment of sinus bradycardia</span><span class="headingEndMark"> — </span>Normalization of post-transplant SND and bradyarrhythmias occurs spontaneously in up to 55 percent of patients during the first three postoperative months and a conservative strategy is reasonable in the early postoperative period [<a href="#rid15">15</a>]. </p><p>The administration of <a class="drug drug_general" data-topicid="10281" href="/d/drug information/10281.html" rel="external">theophylline</a> [<a href="#rid33">33,34</a>] <a class="drug drug_general" data-topicid="9977" href="/d/drug information/9977.html" rel="external">terbutaline</a> [<a href="#rid35">35</a>], or <a class="drug drug_general" data-topicid="9396" href="/d/drug information/9396.html" rel="external">albuterol</a> has been advocated to increase the sinus rate and avoid implantation of a permanent pacemaker during the first three postoperative months. Studies comparing the acute effects of these agents, however, have demonstrated only a modest shortening of the sinus node cycle length and recovery time, with incomplete correction of the underlying sinus node abnormality [<a href="#rid36">36,37</a>]. Thus, these drugs are probably best reserved for patients with only mild or moderate SND or those with postoperative bradycardia due to prior <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a> use. </p><p><a class="drug drug_general" data-topicid="8983" href="/d/drug information/8983.html" rel="external">Atropine</a> is not an effective treatment for bradycardia in the transplanted heart when vagal innervation is absent. Intravenous <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> is suggested in the unlikely event that emergency treatment of bradycardia is needed in the heart transplant patient who does not have pacemaker wires in place. </p><p>Patients with more severe bradycardia that persists for more than two weeks after transplantation usually require a permanent pacemaker; a rate-responsive dual chamber or atrial pacemaker implanted in the donor right atrium (if intact atrioventricular conduction is present) is recommended [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/d/html/950.html" rel="external">"Modes of cardiac pacing: Nomenclature and selection"</a>.)</p><p>The role of biventricular pacing is not known in cardiac transplant recipients who fulfill the criteria used for such therapy in nontransplant patients. Successful implementation of cardiac resynchronization therapy in heart transplant patients has been reported [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/d/html/3475.html" rel="external">"Cardiac resynchronization therapy in heart failure: Indications and choice of system"</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">CONDUCTION DISTURBANCES</span><span class="headingEndMark"> — </span>The most common conduction abnormality following orthotopic heart transplant is a new right bundle branch delay not present on the donor electrocardiogram (ECG) prior to transplantation. This can occur in up to 70 percent of patients and is usually manifest as an incomplete right bundle branch block present immediately postoperatively [<a href="#rid40">40</a>]. The conduction abnormality may persist and, in one study, was associated with prolonged donor ischemic time and multiple episodes of rejection [<a href="#rid41">41</a>]. These findings were corroborated in a later report in which early RBBB was correlated with transpulmonary gradient before orthotopic heart transplant and late occurrence was correlated with higher rejection scores [<a href="#rid42">42</a>]. The incidence of RBBB was higher with biatrial versus bicaval anastomosis.</p><p>Potential mechanisms for later right bundle branch block include right ventricular hypertrophy from elevated pulmonary pressures or damage to the right bundle from endomyocardial biopsy sampling of the right ventricular septal wall. (See  <a class="medical medical_review" href="/d/html/915.html" rel="external">"Right bundle branch block"</a>.)</p><p>Although the transplanted heart is denervated, atrioventricular (AV) nodal function is intact and the ability of the AV node to adapt to exercise with a shortening of the PR interval is retained since it remains sensitive to circulating catecholamines [<a href="#rid43">43</a>]. High grade AV block is uncommon, particularly in the early postoperative period [<a href="#rid16">16</a>]. Although pacemaker implantation is performed in approximately 10 to 15 percent of cardiac transplant recipients, AV block accounts for less than 20 percent of these cases [<a href="#rid22">22,44,45</a>] and median time to pacemaker implantation is later for AV block than for sinus node dysfunction (eg, 1511 versus 27 days [<a href="#rid19">19</a>]). The late development of heart block has been associated with an increase in mortality, often from transplant arteriopathy [<a href="#rid46">46</a>]. (See  <a class="medical medical_review" href="/d/html/3522.html" rel="external">"Heart transplantation: Clinical manifestations, diagnosis, and prognosis of cardiac allograft vasculopathy"</a>.)</p><p>Indications for pacemaker placement are the same as for other patients with symptomatic bradyarrhythmias or chronotropic incompetence that are not expected to resolve. Patients who undergo bicaval cardiac transplants are less likely to require permanent cardiac pacing than those who undergo biatrial cardiac transplants [<a href="#rid47">47</a>] (see  <a class="medical medical_review" href="/d/html/941.html" rel="external">"Permanent cardiac pacing: Overview of devices and indications"</a>).</p><p class="headingAnchor" id="H5"><span class="h1">SUPRAVENTRICULAR ARRHYTHMIAS</span></p><p class="headingAnchor" id="H6"><span class="h2">Atrial premature beats</span><span class="headingEndMark"> — </span>Isolated premature atrial complex (PAC; also referred to a premature atrial beat, premature supraventricular complex, or premature supraventricular beat)</p><p>and nonsustained atrial dysrhythmias are common in the early postoperative period, occurring in up to 76 percent of patients [<a href="#rid16">16,48,49</a>]. (See  <a class="medical medical_review" href="/d/html/932.html" rel="external">"Supraventricular premature beats"</a>.) The prevalence is lower at long-term follow-up, decreasing from 55 percent in the early postoperative period to 30 percent at mean of 24 months after transplantation in one report [<a href="#rid48">48</a>]. There are conflicting data on whether PACs occur with increased frequency during episodes of rejection [<a href="#rid49">49,50</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Atrial fibrillation or flutter</span><span class="headingEndMark"> — </span>Reports of patients with atrial fibrillation (AF) or atrial flutter following cardiac transplantation have variably included perioperative and late arrhythmia. Atrial fibrillation has been described in 10 to 24 percent of patients [<a href="#rid51">51-53</a>], while atrial flutter has been described in 12 to 15 percent [<a href="#rid49">49,53</a>]. These arrhythmias often occur in the absence of significant rejection, although this has not been found in all reports [<a href="#rid49">49,51,52,54</a>]. </p><p>Most episodes of AF occur within the first 30 to 60 days after transplantation with incidence ranging from 5 to 11 percent in large, single center experiences. This relatively low rate, compared to typical post-pericardiectomy AF incidence is postulated to be due to surgical pulmonary vein isolation and cardiac denervation, which occurs with the heart transplantation surgery. Patients treated with long-term <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a> therapy prior to heart transplantation have less early postoperative atrial fibrillation with no adverse impact on mortality [<a href="#rid55">55</a>]. Late AF develops in 5 to 10 percent of patients and is associated with decrease in systolic function and increased overall mortality [<a href="#rid51">51,53,56,57</a>]. Atrial flutter may be a more common late arrhythmia [<a href="#rid49">49</a>].</p><p>Atrial flutter that occurs in the absence of rejection is a result of a macroreentrant circuit in a counterclockwise direction around the tricuspid ring, similar to that seen in typical atrial flutter in normal hearts [<a href="#rid58">58-60</a>]. This circuit includes the isthmus between the tricuspid valve and the inferior vena cava, referred to as the cavotricuspid isthmus. (See  <a class="medical medical_review" href="/d/html/1061.html" rel="external">"Electrocardiographic and electrophysiologic features of atrial flutter"</a>.)</p><p>The cause of atrial dysrhythmias during rejection is not known. It is possible that the patchy nature of rejection results in heterogeneous impairment of atrial conduction and refractoriness, allowing for the formation of multiple microreentrant circuits. In addition, atrial hemodynamics may be altered by the reduced ventricular function and compliance that occur during rejection. (See  <a class="medical medical_review" href="/d/html/1014.html" rel="external">"The electrocardiogram in atrial fibrillation"</a>.)</p><p>Treatment of these arrhythmias includes control of the ventricular response rate and, if warranted, immunosuppressive therapy for rejection. Overdrive pacing can be performed at the time of myocardial biopsy with more than a 90 percent success in terminating atrial flutter [<a href="#rid54">54</a>].</p><p>There are case reports and small series of successful radiofrequency ablation of atrial flutter in transplanted hearts [<a href="#rid59">59,60</a>]. Interestingly, the usual suture line between the donor and recipient heart lies within the cavo-tricuspid isthmus, which, as noted above, is a critical component of the circuit of typical atrial flutter. In a series of six cardiac transplant recipients undergoing cardiac electrophysiologic studies (EPS) for atrial flutter, only the tissue below the suture line from the donor heart was part of the macroreentrant circuit. In all of these cases, ablation from the tricuspid annulus to the suture line, rather than all the way to the inferior vena cava (IVC), successfully eliminated atrial flutter [<a href="#rid60">60</a>]. Macroreentry based on the gaps in the atrial anastomosis line and microreentrant/focal atrial tachycardias successfully treated with radiofrequency ablation have been described [<a href="#rid61">61,62</a>]. (See  <a class="medical medical_review" href="/d/html/1069.html" rel="external">"Restoration of sinus rhythm in atrial flutter"</a>.)</p><p>Heart transplant guidelines do not discuss anticoagulation in the setting of heart transplant patients with atrial fibrillation or atrial flutter. Standard guidelines for anticoagulation in patients with atrial fibrillation or atrial flutter should be followed in heart transplant patients. (See  <a class="medical medical_review" href="/d/html/1031.html" rel="external">"Atrial fibrillation in adults: Use of oral anticoagulants"</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Supraventricular tachycardias</span><span class="headingEndMark"> — </span>A variety of supraventricular arrhythmias can occur in orthotopic heart transplant recipients, including atrioventricular (AV) reentrant tachycardia involving a concealed AV bypass tract [<a href="#rid63">63-65</a>], Wolff-Parkinson-White syndrome [<a href="#rid66">66,67</a>], and sustained atrial tachycardias [<a href="#rid52">52,68</a>]. Radiofrequency catheter ablation has been performed in many of these patients with success and complication rates similar to nontransplant recipients [<a href="#rid65">65,67,68</a>]. (See  <a class="medical medical_review" href="/d/html/943.html" rel="external">"Narrow QRS complex tachycardias: Clinical manifestations, diagnosis, and evaluation"</a> and  <a class="medical medical_review" href="/d/html/1007.html" rel="external">"Overview of catheter ablation of cardiac arrhythmias", section on 'Introduction'</a>.)</p><p class="headingAnchor" id="H2965829348"><span class="h2">Interaction of diltiazem with immunosuppressive agents</span><span class="headingEndMark"> — </span>Clinicians should be aware of drug interaction between <a class="drug drug_general" data-topicid="9365" href="/d/drug information/9365.html" rel="external">diltiazem</a> and immunosuppressive agents. Intravenous diltiazem is often used to control ventricular rates in patients with SVTs and/or atrial fibrillation. Diltiazem inhibits CYP3A, which metabolizes <a class="drug drug_general" data-topicid="9971" href="/d/drug information/9971.html" rel="external">tacrolimus</a> and <a class="drug drug_general" data-topicid="9217" href="/d/drug information/9217.html" rel="external">cyclosporine</a>. Consequently, heart transplant patients receiving diltiazem often have elevated tacrolimus or cyclosporine levels which can result in renal dysfunction [<a href="#rid69">69</a>]. </p><p class="headingAnchor" id="H9"><span class="h1">VENTRICULAR ARRHYTHMIAS</span></p><p class="headingAnchor" id="H10"><span class="h2">Ventricular premature beats and nonsustained ventricular tachycardia</span><span class="headingEndMark"> — </span>Ventricular premature beats (VPBs) are common in the early post-transplant period, occurring in up to 100 percent of patients [<a href="#rid16">16,49</a>]. (See  <a class="medical medical_review" href="/d/html/994.html" rel="external">"Premature ventricular complexes: Clinical presentation and diagnostic evaluation"</a>.) The incidence of VPBs decreases after the early postoperative period and does not appear to be associated with rejection or other factors.</p><p>The frequency of nonsustained ventricular tachycardia (NSVT) also decreases over time [<a href="#rid48">48</a>]. However, some studies have demonstrated an association with both rejection and coronary atherosclerosis (cardiac allograft vasculopathy) [<a href="#rid16">16,70</a>]. In one small series, for example, complex ventricular ectopy (multifocal VPBs and couplets) occurring in the late transplant period was also more prevalent in patients with severe cardiac allograft vasculopathy [<a href="#rid50">50</a>]. (See  <a class="medical medical_review" href="/d/html/3522.html" rel="external">"Heart transplantation: Clinical manifestations, diagnosis, and prognosis of cardiac allograft vasculopathy"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Sustained ventricular arrhythmias and sudden cardiac death</span><span class="headingEndMark"> — </span>Standard recommendations for ICD therapy apply to cardiac transplant recipients. Antiarrhythmic drug therapy is based on safety, tolerability, and clinical experience as limited published evidence is available for these drugs in cardiac transplant recipients. (See  <a class="medical medical_review" href="/d/html/91077.html" rel="external">"Primary prevention of sudden cardiac death in patients with cardiomyopathy and heart failure with reduced LVEF"</a> and  <a class="medical medical_review" href="/d/html/946.html" rel="external">"Secondary prevention of sudden cardiac death in heart failure and cardiomyopathy"</a> and  <a class="medical medical_review" href="/d/html/1040.html" rel="external">"Sustained monomorphic ventricular tachycardia in patients with structural heart disease: Treatment and prognosis"</a>.)</p><p>Sustained ventricular arrhythmias are uncommon in the donor heart; when they occur, they are usually associated with either severe transplant cardiac allograft vasculopathy or allograft rejection [<a href="#rid71">71</a>]. Ventricular fibrillation has been reported in patients hospitalized for severe allograft rejection [<a href="#rid72">72,73</a>], while autopsy studies of patients with sudden cardiac death have demonstrated a high prevalence of severe cardiac allograft vasculopathy or recent myocardial infarctions [<a href="#rid72">72,74</a>]. Although ventricular tachyarrhythmias are thought to be the mode of sudden cardiac death, severe bradycardic events as well as electromechanical dissociation may also occur due to advanced atherosclerosis [<a href="#rid75">75</a>]. </p><p>Limited outcome data exist for implantable cardioverter-defibrillator therapy (ICD) in heart transplant recipients. ICD therapy has been reported to effectively terminate ventricular arrhythmias in transplanted patients with severe left ventricular dysfunction, severe allograft vasculopathy, or history of cardiac arrest [<a href="#rid76">76</a>]. The effect of ICD therapy on long-term survival and quality of life in this population is not known. </p><p class="headingAnchor" id="H1005330758"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112260.html" rel="external">"Society guideline links: Arrhythmias in adults"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/3439.html" rel="external">"Patient education: Heart transplantation (Beyond the Basics)"</a>) </p><p></p><p class="headingAnchor" id="H13"><span class="h1">SUMMARY</span><span class="headingEndMark"> — </span>While most arrhythmias after orthotopic heart transplantation are benign, there are several clinical associations with which the physician must be familiar:</p><p class="bulletIndent1"><span class="glyph">●</span>Early postoperative bradyarrhythmias due to sinus node dysfunction (SND) are probably caused by surgical trauma to the sinoatrial node or its blood supply and can partly be avoided using a bicaval anastomosis technique. (See <a class="local">'Sinus node dysfunction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8983" href="/d/drug information/8983.html" rel="external">Atropine</a> is not an effective treatment for bradycardia when vagal innervation is absent; intravenous <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> is suggested in the unlikely event that emergency treatment of bradycardia is needed in the heart transplant patient without pacemaker wires in place. (See <a class="local">'Treatment of sinus bradycardia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sustained atrial flutter and fibrillation are commonly associated with allograft rejection. Thus, the presence of these arrhythmias should prompt a search for acute rejection by endomyocardial biopsy. Empiric steroid therapy should be considered in such patients prior to return of the biopsy results. <a class="drug drug_general" data-topicid="9359" href="/d/drug information/9359.html" rel="external">Adenosine</a> should not be used to try to elucidate the mechanism of supraventricular tachyarrhythmias since it can result in transient, but significant, bradyarrhythmias. (See <a class="local">'Atrial fibrillation or flutter'</a> above and  <a class="medical medical_review" href="/d/html/3520.html" rel="external">"Heart transplantation in adults: Treatment of rejection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complex ventricular ectopy or atrioventricular block may be caused by either acute rejection or severe cardiac allograft vasculopathy. Affected patients should undergo endomyocardial biopsy followed, if rejection is not present, by coronary angiography to diagnose cardiac allograft vasculopathy. (See <a class="local">'Ventricular arrhythmias'</a> above and <a class="local">'Conduction disturbances'</a> above and  <a class="medical medical_review" href="/d/html/3522.html" rel="external">"Heart transplantation: Clinical manifestations, diagnosis, and prognosis of cardiac allograft vasculopathy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Insertion of a permanent pacemaker should be considered in patients with significant bradyarrhythmias, either from SND or high grade atrioventricular (AV) block, that are associated with decreased cardiac output and occur in the absence of acute rejection. (See <a class="local">'Treatment of sinus bradycardia'</a> above and <a class="local">'Conduction disturbances'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with frequent and symptomatic supraventricular tachycardia may be treated with radiofrequency catheter ablation. (See <a class="local">'Supraventricular tachycardias'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Standard recommendations for ICD therapy apply to cardiac transplant recipients. Antiarrhythmic drug therapy is based on safety, tolerability, and clinical experience as limited published evidence is available for these drugs in cardiac transplant recipients. (See <a class="local">'Ventricular arrhythmias'</a> above and  <a class="medical medical_review" href="/d/html/91077.html" rel="external">"Primary prevention of sudden cardiac death in patients with cardiomyopathy and heart failure with reduced LVEF"</a> and  <a class="medical medical_review" href="/d/html/946.html" rel="external">"Secondary prevention of sudden cardiac death in heart failure and cardiomyopathy"</a> and  <a class="medical medical_review" href="/d/html/1040.html" rel="external">"Sustained monomorphic ventricular tachycardia in patients with structural heart disease: Treatment and prognosis"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Calzolari V, Angelini A, Basso C, et al. Histologic findings in the conduction system after cardiac transplantation and correlation with electrocardiographic findings. Am J Cardiol 1999; 84:756.</a></li><li><a class="nounderline abstract_t">Knight CS, Tallaj JA, Rayburn BK, et al. Bradycardia and syncope as a presentation of cardiac allograft rejection involving the conducting system. Cardiovasc Pathol 2010; 19:117.</a></li><li><a class="nounderline abstract_t">Cannom DS, Rider AK, Stinson EB, Harrison DC. Electrophysiologic studies in the denervated transplanted human heart. II. Response to norepinephrine, isoproterenol and propranolol. Am J Cardiol 1975; 36:859.</a></li><li><a class="nounderline abstract_t">Yusuf S, Theodoropoulos S, Mathias CJ, et al. Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockade. Circulation 1987; 75:696.</a></li><li><a class="nounderline abstract_t">Ellenbogen KA, Thames MD, DiMarco JP, et al. Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity. Circulation 1990; 81:821.</a></li><li><a class="nounderline abstract_t">Flyer JN, Zuckerman WA, Richmond ME, et al. Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplantation. Circulation 2017; 135:2485.</a></li><li><a class="nounderline abstract_t">Burke MN, McGinn AL, Homans DC, et al. Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans. Circulation 1995; 91:72.</a></li><li><a class="nounderline abstract_t">Squires RW, Leung TC, Cyr NS, et al. Partial normalization of the heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacity. Mayo Clin Proc 2002; 77:1295.</a></li><li><a class="nounderline abstract_t">Wilson RF, Johnson TH, Haidet GC, et al. Sympathetic reinnervation of the sinus node and exercise hemodynamics after cardiac transplantation. Circulation 2000; 101:2727.</a></li><li><a class="nounderline abstract_t">Gallego-Page JC, Segovia J, Alonso-Pulpón L, et al. Re-innervation after heart transplantation: a multidisciplinary study. J Heart Lung Transplant 2004; 23:674.</a></li><li><a class="nounderline abstract_t">Bengel FM, Ueberfuhr P, Ziegler SI, et al. Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 hydroxyephedrine. Circulation 1999; 99:1866.</a></li><li><a class="nounderline abstract_t">Arrowood JA, Minisi AJ, Goudreau E, et al. Absence of parasympathetic control of heart rate after human orthotopic cardiac transplantation. Circulation 1997; 96:3492.</a></li><li><a class="nounderline abstract_t">Bernardi L, Valenti C, Wdowczyck-Szulc J, et al. Influence of type of surgery on the occurrence of parasympathetic reinnervation after cardiac transplantation. Circulation 1998; 97:1368.</a></li><li><a class="nounderline abstract_t">Rivinius R, Helmschrott M, Ruhparwar A, et al. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart. Clin Res Cardiol 2018; 107:138.</a></li><li><a class="nounderline abstract_t">Heinz G, Hirschl M, Buxbaum P, et al. Sinus node dysfunction after orthotopic cardiac transplantation: postoperative incidence and long-term implications. Pacing Clin Electrophysiol 1992; 15:731.</a></li><li><a class="nounderline abstract_t">Jacquet L, Ziady G, Stein K, et al. Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol 1990; 16:832.</a></li><li><a class="nounderline abstract_t">Mackintosh AF, Carmichael DJ, Wren C, et al. Sinus node function in first three weeks after cardiac transplantation. Br Heart J 1982; 48:584.</a></li><li><a class="nounderline abstract_t">Heinz G, Kratochwill C, Koller-Strametz J, et al. Benign prognosis of early sinus node dysfunction after orthotopic cardiac transplantation. Pacing Clin Electrophysiol 1998; 21:422.</a></li><li><a class="nounderline abstract_t">Wellmann P, Herrmann FE, Hagl C, Juchem G. A Single Center Study of 1,179 Heart Transplant Patients-Factors Affecting Pacemaker Implantation. Pacing Clin Electrophysiol 2017; 40:247.</a></li><li><a class="nounderline abstract_t">Woodard DA, Conti JB, Mills RM Jr, et al. Permanent atrial pacing in cardiac transplant patients. Pacing Clin Electrophysiol 1997; 20:2398.</a></li><li class="breakAll">Mason JW, Harrison DC. Electrophysiology and electropharmacology of the transplanted human heart. In: Cardiac Arrhythmias: Electrophysiology, Diagnosis and Management, Narula OS (Ed), Williams &amp; Wilkins, Baltimore 1979. p.66.</li><li><a class="nounderline abstract_t">DiBiase A, Tse TM, Schnittger I, et al. Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol 1991; 67:1385.</a></li><li><a class="nounderline abstract_t">Dreyfus G, Jebara V, Mihaileanu S, Carpentier AF. Total orthotopic heart transplantation: an alternative to the standard technique. Ann Thorac Surg 1991; 52:1181.</a></li><li><a class="nounderline abstract_t">Sarsam MA, Campbell CS, Yonan NA, et al. An alternative surgical technique in orthotopic cardiac transplantation. J Card Surg 1993; 8:344.</a></li><li><a class="nounderline abstract_t">Aziz TM, Burgess MI, El-Gamel A, et al. Orthotopic cardiac transplantation technique: a survey of current practice. Ann Thorac Surg 1999; 68:1242.</a></li><li><a class="nounderline abstract_t">Deleuze PH, Benvenuti C, Mazzucotelli JP, et al. Orthotopic cardiac transplantation with direct caval anastomosis: is it the optimal procedure? J Thorac Cardiovasc Surg 1995; 109:731.</a></li><li><a class="nounderline abstract_t">el Gamel A, Yonan NA, Grant S, et al. Orthotopic cardiac transplantation: a comparison of standard and bicaval Wythenshawe techniques. J Thorac Cardiovasc Surg 1995; 109:721.</a></li><li><a class="nounderline abstract_t">Rothman SA, Jeevanandam V, Combs WG, et al. Eliminating bradyarrhythmias after orthotopic heart transplantation. Circulation 1996; 94:II278.</a></li><li><a class="nounderline abstract_t">Davies RR, Russo MJ, Morgan JA, et al. Standard versus bicaval techniques for orthotopic heart transplantation: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2010; 140:700.</a></li><li><a class="nounderline abstract_t">Heinz G, Ohner T, Laufer G, et al. Demographic and perioperative factors associated with initial and prolonged sinus node dysfunction after orthotopic heart transplantation. The impact of ischemic time. Transplantation 1991; 51:1217.</a></li><li><a class="nounderline abstract_t">Miyamoto Y, Curtiss EI, Kormos RL, et al. Bradyarrhythmia after heart transplantation. Incidence, time course, and outcome. Circulation 1990; 82:IV313.</a></li><li><a class="nounderline abstract_t">Cantillon DJ, Tarakji KG, Hu T, et al. Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database. Heart Rhythm 2010; 7:1567.</a></li><li><a class="nounderline abstract_t">Redmond JM, Zehr KJ, Gillinov MA, et al. Use of theophylline for treatment of prolonged sinus node dysfunction in human orthotopic heart transplantation. J Heart Lung Transplant 1993; 12:133.</a></li><li><a class="nounderline abstract_t">Ellenbogen KA, Szentpetery S, Katz MR. Reversibility of prolonged chronotropic dysfunction with theophylline following orthotopic cardiac transplantation. Am Heart J 1988; 116:202.</a></li><li><a class="nounderline abstract_t">Cook LS, Will KR, Moran J. Treatment of junctional rhythm after heart transplantation with terbutaline. J Heart Transplant 1989; 8:342.</a></li><li><a class="nounderline abstract_t">Rothman SA, Jeevanandam V, Seeber CP, et al. Electrophysiologic effects of intravenous aminophylline in heart transplant recipients with sinus node dysfunction. J Heart Lung Transplant 1995; 14:429.</a></li><li><a class="nounderline abstract_t">Rothman SA, Jeevanandam V, Hsia H, et al. A comparison of the electrophysiologic effects of aminophylline and terbutaline in heart transplant recipients with sinus node dysfunction (abstract). Circulation 1995; 92(Suppl 1):I.</a></li><li><a class="nounderline abstract_t">Melton IC, Gilligan DM, Wood MA, Ellenbogen KA. Optimal cardiac pacing after heart transplantation. Pacing Clin Electrophysiol 1999; 22:1510.</a></li><li><a class="nounderline abstract_t">Mariani JA, McDonald MA, Nanthakumar K, et al. Cardiac resynchronization therapy after atrioventricular node ablation for rapid atrial fibrillation in a heart transplant recipient with late allograft dysfunction. J Heart Lung Transplant 2010; 29:704.</a></li><li><a class="nounderline abstract_t">Villa AE, de Marchena EJ, Myerburg RJ, Castellanos A. Comparisons of paired orthotopic cardiac transplant donor and recipient electrocardiograms. Am Heart J 1994; 127:70.</a></li><li><a class="nounderline abstract_t">Leonelli FM, Pacifico A, Young JB. Frequency and significance of conduction defects early after orthotopic heart transplantation. Am J Cardiol 1994; 73:175.</a></li><li><a class="nounderline abstract_t">Ferretto S, Tafciu E, Giuliani I, et al. Interventricular conduction disorders after orthotopic heart transplantation: risk factors and clinical relevance. Ann Noninvasive Electrocardiol 2017; 22.</a></li><li><a class="nounderline abstract_t">Koller-Strametz J, Kratochwill C, Grabenwöger M, et al. PR interval adaptation in the denervated transplanted heart. Pacing Clin Electrophysiol 1997; 20:1247.</a></li><li><a class="nounderline abstract_t">Heinz G, Kratochwill C, Hirschl M, et al. Normal AV node function in patients with sinus node dysfunction after cardiac transplantation. J Card Surg 1993; 8:417.</a></li><li><a class="nounderline abstract_t">Markewitz A, Schmoeckel M, Nollert G, et al. Long-term results of pacemaker therapy after orthotopic heart transplantation. J Card Surg 1993; 8:411.</a></li><li><a class="nounderline abstract_t">Ruben S, Hsia H, Mather P, et al. Etiology and prognostic implications of post-transplant conduction system disease (abstract). J Heart Lung Transplant 1996; 15:S60.</a></li><li><a class="nounderline abstract_t">Weiss ES, Nwakanma LU, Russell SB, et al. Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database. J Heart Lung Transplant 2008; 27:178.</a></li><li><a class="nounderline abstract_t">Little RE, Kay GN, Epstein AE, et al. Arrhythmias after orthotopic cardiac transplantation. Prevalence and determinants during initial hospitalization and late follow-up. Circulation 1989; 80:III140.</a></li><li><a class="nounderline abstract_t">Scott CD, Dark JH, McComb JM. Arrhythmias after cardiac transplantation. Am J Cardiol 1992; 70:1061.</a></li><li><a class="nounderline abstract_t">Romhilt DW, Doyle M, Sagar KB, et al. Prevalence and significance of arrhythmias in long-term survivors of cardiac transplantation. Circulation 1982; 66:I219.</a></li><li><a class="nounderline abstract_t">Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56:539.</a></li><li><a class="nounderline abstract_t">Pavri BB, O'Nunain SS, Newell JB, et al. Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation. J Am Coll Cardiol 1995; 25:1673.</a></li><li><a class="nounderline abstract_t">Ahmari SA, Bunch TJ, Chandra A, et al. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. J Heart Lung Transplant 2006; 25:53.</a></li><li><a class="nounderline abstract_t">Macdonald P, Hackworthy R, Keogh A, et al. Atrial overdrive pacing for reversion of atrial flutter after heart transplantation. J Heart Lung Transplant 1991; 10:731.</a></li><li><a class="nounderline abstract_t">Rivinius R, Helmschrott M, Ruhparwar A, et al. Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation. Drug Des Devel Ther 2016; 10:677.</a></li><li><a class="nounderline abstract_t">Cohn WE, Gregoric ID, Radovancevic B, et al. Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases. Ann Thorac Surg 2008; 85:56.</a></li><li><a class="nounderline abstract_t">Dasari TW, Pavlovic-Surjancev B, Patel N, et al. Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation. Am J Cardiol 2010; 106:737.</a></li><li><a class="nounderline abstract_t">Arenal A, Almendral J, Muñoz R, et al. Mechanism and location of atrial flutter in transplanted hearts: observations during transient entrainment from distant sites. J Am Coll Cardiol 1997; 30:539.</a></li><li><a class="nounderline abstract_t">Pinski SL, Bredikis AJ, Winkel E, Trohman RG. Radiofrequency catheter ablation of atrial flutter after orthotopic heart transplantation: insights into the redefined critical isthmus. J Heart Lung Transplant 1999; 18:292.</a></li><li><a class="nounderline abstract_t">Marine JE, Schuger CD, Bogun F, et al. Mechanism of atrial flutter occurring late after orthotopic heart transplantation with atrio-atrial anastomosis. Pacing Clin Electrophysiol 2005; 28:412.</a></li><li><a class="nounderline abstract_t">Li YG, Grönefeld G, Israel C, et al. Radiofrequency catheter ablation in patients with symptomatic atrial flutter/tachycardia after orthotopic heart transplantation. Chin Med J (Engl) 2006; 119:2036.</a></li><li><a class="nounderline abstract_t">Nof E, Stevenson WG, Epstein LM, et al. Catheter ablation of atrial arrhythmias after cardiac transplantation: findings at EP study utility of 3-D mapping and outcomes. J Cardiovasc Electrophysiol 2013; 24:498.</a></li><li><a class="nounderline abstract_t">Goy JJ, Kappenberger L, Turina M. Wolff-Parkinson-White syndrome after transplantation of the heart. Br Heart J 1989; 61:368.</a></li><li><a class="nounderline abstract_t">Gallay P, Albat B, Thevenet A, Grolleau R. Direct current catheter ablation of an accessory pathway in a recipient with refractory reciprocal tachycardia. J Heart Lung Transplant 1992; 11:442.</a></li><li><a class="nounderline abstract_t">Neuzner J, Friedl A, Pitschner HF. Radiofrequency catheter ablation of a concealed accessory atrioventricular pathway after heart transplantation. Pacing Clin Electrophysiol 1994; 17:1778.</a></li><li><a class="nounderline abstract_t">Thompson E, Steinhaus D, Long N, Borkon AM. Preexcitation syndrome in a donor heart. J Heart Transplant 1989; 8:177.</a></li><li><a class="nounderline abstract_t">Rothman SA, Hsia HH, Bove AA, et al. Radiofrequency ablation of Wolff-Parkinson-White syndrome in a donor heart after orthotopic heart transplantation. J Heart Lung Transplant 1994; 13:905.</a></li><li><a class="nounderline abstract_t">Ott P, Kelly PA, Mann DE, et al. Tachycardia-induced cardiomyopathy in a cardiac transplant recipient: treatment with radiofrequency catheter ablation. J Cardiovasc Electrophysiol 1995; 6:391.</a></li><li><a class="nounderline abstract_t">Hebert MF, Lam AY. Diltiazem increases tacrolimus concentrations. Ann Pharmacother 1999; 33:680.</a></li><li><a class="nounderline abstract_t">Park JK, Hsu DT, Hordof AJ, Addonizio LJ. Arrhythmias in pediatric heart transplant recipients: prevalence and association with death, coronary artery disease, and rejection. J Heart Lung Transplant 1993; 12:956.</a></li><li><a class="nounderline abstract_t">Alexopoulos D, Yusuf S, Bostock J, et al. Ventricular arrhythmias in long term survivors of orthotopic and heterotopic cardiac transplantation. Br Heart J 1988; 59:648.</a></li><li><a class="nounderline abstract_t">Berke DK, Graham AF, Schroeder JS, Harrison DC. Arrhythmias in the denervated transplanted human heart. Circulation 1973; 48:III112.</a></li><li><a class="nounderline abstract_t">de Jonge N, Jambroes G, Lahpor JR, Woolley SR. Ventricular fibrillation during acute rejection after heart transplantation. J Heart Lung Transplant 1992; 11:797.</a></li><li><a class="nounderline abstract_t">Uretsky BF, Kormos RL, Zerbe TR, et al. Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography. J Heart Lung Transplant 1992; 11:S45.</a></li><li><a class="nounderline abstract_t">Grinstead WC, Smart FW, Pratt CM, et al. Sudden death caused by bradycardia and asystole in a heart transplant patient with coronary arteriopathy. J Heart Lung Transplant 1991; 10:931.</a></li><li><a class="nounderline abstract_t">Tsai VW, Cooper J, Garan H, et al. The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry. Circ Heart Fail 2009; 2:197.</a></li></ol></div><div id="topicVersionRevision">Topic 3518 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10498155" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Histologic findings in the conduction system after cardiac transplantation and correlation with electrocardiographic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19144548" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Bradycardia and syncope as a presentation of cardiac allograft rejection involving the conducting system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1106169" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Electrophysiologic studies in the denervated transplanted human heart. II. Response to norepinephrine, isoproterenol and propranolol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2881634" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2306833" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28450351" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7646628" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12479515" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Partial normalization of the heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10851211" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Sympathetic reinnervation of the sinus node and exercise hemodynamics after cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15366426" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Re-innervation after heart transplantation: a multidisciplinary study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10199884" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 hydroxyephedrine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9396446" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Absence of parasympathetic control of heart rate after human orthotopic cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9577948" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Influence of type of surgery on the occurrence of parasympathetic reinnervation after cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29098378" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1382274" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Sinus node dysfunction after orthotopic cardiac transplantation: postoperative incidence and long-term implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2212366" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6756446" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Sinus node function in first three weeks after cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9507544" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Benign prognosis of early sinus node dysfunction after orthotopic cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28101990" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A Single Center Study of 1,179 Heart Transplant Patients-Factors Affecting Pacemaker Implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9358479" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Permanent atrial pacing in cardiac transplant patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9358479" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Permanent atrial pacing in cardiac transplant patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2042569" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1953150" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Total orthotopic heart transplantation: an alternative to the standard technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8507963" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : An alternative surgical technique in orthotopic cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10543486" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Orthotopic cardiac transplantation technique: a survey of current practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7715221" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Orthotopic cardiac transplantation with direct caval anastomosis: is it the optimal procedure?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7715220" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Orthotopic cardiac transplantation: a comparison of standard and bicaval Wythenshawe techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8901760" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Eliminating bradyarrhythmias after orthotopic heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20584533" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Standard versus bicaval techniques for orthotopic heart transplantation: an analysis of the United Network for Organ Sharing database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2048197" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Demographic and perioperative factors associated with initial and prolonged sinus node dysfunction after orthotopic heart transplantation. The impact of ischemic time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2225423" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Bradyarrhythmia after heart transplantation. Incidence, time course, and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20601151" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8443190" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Use of theophylline for treatment of prolonged sinus node dysfunction in human orthotopic heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3293389" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Reversibility of prolonged chronotropic dysfunction with theophylline following orthotopic cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2671319" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Treatment of junctional rhythm after heart transplantation with terbutaline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7654727" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Electrophysiologic effects of intravenous aminophylline in heart transplant recipients with sinus node dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : A comparison of the electrophysiologic effects of aminophylline and terbutaline in heart transplant recipients with sinus node dysfunction (abstract)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10588154" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Optimal cardiac pacing after heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20227300" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Cardiac resynchronization therapy after atrioventricular node ablation for rapid atrial fibrillation in a heart transplant recipient with late allograft dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8273758" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Comparisons of paired orthotopic cardiac transplant donor and recipient electrocardiograms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8296739" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Frequency and significance of conduction defects early after orthotopic heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27610948" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Interventricular conduction disorders after orthotopic heart transplantation: risk factors and clinical relevance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9170124" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : PR interval adaptation in the denervated transplanted heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8507973" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Normal AV node function in patients with sinus node dysfunction after cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8507972" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Long-term results of pacemaker therapy after orthotopic heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Etiology and prognostic implications of post-transplant conduction system disease (abstract)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18267224" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2805295" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Arrhythmias after orthotopic cardiac transplantation. Prevalence and determinants during initial hospitalization and late follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1384302" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Arrhythmias after cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6177443" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Prevalence and significance of arrhythmias in long-term survivors of cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8379728" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Hazards of postoperative atrial arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7759722" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16399531" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1958679" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Atrial overdrive pacing for reversion of atrial flutter after heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26937171" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18154778" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20723655" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9247530" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Mechanism and location of atrial flutter in transplanted hearts: observations during transient entrainment from distant sites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10226892" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Radiofrequency catheter ablation of atrial flutter after orthotopic heart transplantation: insights into the redefined critical isthmus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15869673" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Mechanism of atrial flutter occurring late after orthotopic heart transplantation with atrio-atrial anastomosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17199953" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Radiofrequency catheter ablation in patients with symptomatic atrial flutter/tachycardia after orthotopic heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23387552" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Catheter ablation of atrial arrhythmias after cardiac transplantation: findings at EP study utility of 3-D mapping and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2653393" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Wolff-Parkinson-White syndrome after transplantation of the heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1610852" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Direct current catheter ablation of an accessory pathway in a recipient with refractory reciprocal tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7838786" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Radiofrequency catheter ablation of a concealed accessory atrioventricular pathway after heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2651623" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Preexcitation syndrome in a donor heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7803435" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Radiofrequency ablation of Wolff-Parkinson-White syndrome in a donor heart after orthotopic heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7551308" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Tachycardia-induced cardiomyopathy in a cardiac transplant recipient: treatment with radiofrequency catheter ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10410178" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Diltiazem increases tacrolimus concentrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8312320" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Arrhythmias in pediatric heart transplant recipients: prevalence and association with death, coronary artery disease, and rejection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3293640" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Ventricular arrhythmias in long term survivors of orthotopic and heterotopic cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4124489" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Arrhythmias in the denervated transplanted human heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1498146" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Ventricular fibrillation during acute rejection after heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1622998" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1756158" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Sudden death caused by bradycardia and asystole in a heart transplant patient with coronary arteriopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19808340" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
